Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007))

F. I. Mulder, N. van Es, N. Kraaijpoel, M. Di Nisio, M. Carrier, A. Duggal, M. Gaddh, D. Garcia, M. A. Grosso, A. K. Kakkar, M. F. Mercuri, S. Middeldorp, G. Royle, A. Segers, S. Shivakumar, P. Verhamme, T. Wang, J. I. Weitz, G. Zhang, H. R. BüllerG. Raskob

Research output: Contribution to journal › Comment/debate › peer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007))'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry